India Coated Tablets Market Outlook to 2028

India Coated Tablets Market Overview

India Coated Tablet Market has been growing at a substantial rate. This is reflected in Global Coated Tablet Market which reached a valuation of $1.1 billion in 2023, driven by the increasing prevalence of chronic diseases, rising healthcare expenditures, and advancements in pharmaceutical formulations.

Key players in the India Coated Tablet Market include Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Lupin Limited, Aurobindo Pharma Limited. These companies dominate the market through extensive product portfolios, significant R&D investments, and strategic collaborations and mergers.

Maharashtra, particularly the city of Mumbai, dominates the India coated tablet market driven by its well-established pharmaceutical industry infrastructure, availability of skilled labor, and proximity to major ports facilitating export activities.

In 2023, Sun Pharma acquired U.S.-based Concert Pharmaceuticals for $576 million to access their experimental drug CTP-543 (deuruxolitinib) for treating patchy baldness (alopecia areata). This strategic acquisition is expected to strengthen Sun Pharma's dermatology portfolio and expand its presence in the U.S. market.

India Coated Tablets Market Segmentation

The India Coated Tablets Market can be segmented based on several factors:

By Product Type: India Coated Tablets Market is segmented by Product Type into Enteric Coated Tablets, Film-Coated Tablets and Sugar-Coated Tablets. In 2023, Film Coated Tablets reign as the most dominant sub-segment because of their widespread use in the treatment of various chronic conditions and their ability to provide improved drug stability and patient compliance.

By Application: India Coated Tablets Market is segmented by Application into Gastrointestinal, Cardiovascular and Anti-Infective. In 2023, cardiovascular emerges as the most dominant sub-segment due to the rising prevalence of cardiovascular diseases and the increasing demand for effective treatment options. Cardiovascular diseases are the leading cause of mortality in the country, driving the demand for advanced drug formulations, including coated tablets.

By Region: India Coated Tablets Market is segmented by region into North, South, East & West. In 2023, North region dominated the market due to the concentration of pharmaceutical manufacturing units and R&D centers. Additionally, supportive government initiatives and incentives for pharmaceutical companies in these states have contributed to their leading market position.

India Coated Tablets Market Competitive Landscape

Company

Establishment Year

Headquarters

Sun Pharmaceutical Industries Ltd.

1983

Mumbai, Maharashtra

Dr. Reddy's Laboratories Ltd.

1984

Hyderabad, Telangana

Cipla Ltd.

1935

Mumbai, Maharashtra

Lupin Limited

1968

Mumbai, Maharashtra

Aurobindo Pharma Limited

1986

Hyderabad, Telangana

Cipla & Sanofi Agreement: In 2024, Cipla has entered into an exclusive distribution agreement with Sanofi India to enhance the reach of Sanofi’s Central Nervous System (CNS) product portfolio in India. This partnership makes Cipla responsible for distributing six CNS brands, including Frisium, a leading anti-epileptic medication.

Reddy's Acquires Novartis Cardiovascular Brand: In 2022, Dr. Reddy's Laboratories has announced the acquisition of the cardiovascular brand Cidmus from Novartis for $61 million. This deal aims to enhance Dr. Reddy's portfolio in the cardiovascular segment within India.

India Coated Tablets Industry Analysis

India Coated Tablets Market Growth Drivers:

Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is a significant driver for the coated tablet market. Till 2022, there were around 14.1 lakh new cancer cases in the country. The growing burden of chronic diseases necessitates effective and patient-friendly drug delivery systems, thereby driving the demand for coated tablets.

Increasing Healthcare Expenditure: The Indian government's allocation for healthcare in the 2024 Union Budget was around INR 86,170 crore in 2023-2024. This increased spending is expected to enhance the production and distribution of pharmaceutical products, including coated tablets, to meet the healthcare needs of the population.

Growing Geriatric Population: The aging population in India is another critical growth driver for the coated tablet market. In 2023, the elderly population aged 60 and above were 153 million. Older adults often require multiple medications, making coated tablets an essential dosage form due to their ease of swallowing and improved taste masking, thus increasing their demand.

India Coated Tablets Market Challenges:

High Cost of Advanced Coating Technologies: The high cost associated with advanced coating technologies is a significant challenge for the coated tablet market. Developing new coating formulations and scaling up production involves substantial investment, making it difficult for small and medium-sized enterprises (SMEs) to compete in the market.

Limited Access to Raw Materials: The availability and cost of raw materials required for tablet coating, such as polymers and colorants, can be a constraint. The fluctuating prices and limited supply of high-quality raw materials can affect production schedules and profit margins.

India Coated Tablets Market Government Initiatives:

Pharma Vision 2020: The Indian government launched the Pharma Vision 2020 initiative aimed at making India a global leader in end-to-end drug manufacturing. This initiative includes tax benefits, subsidies, and streamlined regulatory processes for pharmaceutical companies. The government allocated INR 5,000 crore towards developing pharmaceutical parks and R&D centers, fostering innovation and growth in the coated tablet market.

Ayushman Bharat Scheme: In 2018, the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) was launched. It is the world's largest publicly funded health insurance scheme, providing coverage of up to ₹5 lakh per family per year for secondary and tertiary care. In the 2024 interim budget, the government increased the allocation for AB-PMJAY to ₹7,200 crore. Also, the insurance coverage under AB-PMJAY is also expected to be doubled from the current ₹5 lakh to ₹10 lakh per family.

India Coated Tablets Future Market Outlook

India Coated Tablet Market is projected to continue its robust growth trajectory as the market will be driven by ongoing advancements in drug formulation technologies, increasing healthcare access, and a growing focus on personalized medicine.

Future Trends

Increased Adoption of Personalized Medicine: The trend towards personalized medicine is expected to drive the demand for customized coated tablet formulations. By 2028, pharmaceutical companies will increasingly focus on developing tailored drug delivery systems that cater to individual patient needs. This shift will require advancements in coating technologies to enable precise control over drug release profiles and dosage forms.

Growth in Biopharmaceuticals: The biopharmaceutical sector is projected to witness significant growth, influencing the coated tablet market driven by advancements in biotechnology and the development of biologics. Coated tablets will play a crucial role in the oral delivery of biopharmaceuticals, necessitating innovations in coating techniques to protect sensitive biological molecules.
Please Note: It will take 5-7 business days to complete the report upon order confirmation